Explore advances in von Willebrand disease treatment, including Star Therapeutics' VGA039, and other key players in the space ...

The final month of 2024 saw Nuvig Therapeutics come top of the private biotech fundraising list. The company raised $161 million in a series B round, as it aims to deliver novel methods for reducing ...

A blockbuster drug is a therapy that generates at least $1 billion in sales. Clarivate’s Drugs to Watch 2025 report includes treatments that were approved last year or expected to debut this year and ...

In the last year or so, there have been a number of indications that Saudi Arabia is setting itself up to become a global biotech hub. Over the next decade, it is expected to become a world leader in ...